Searchable abstracts of presentations at key conferences in endocrinology

ea0084ps2-07-63 | Graves’ Disease 1 | ETA2022

Corticosteroids and mycophenolic acid have a synergistic effect on chemokines secretion in orbital cells from patients with graves’ ophthalmopathy

Martina Ferrari Silvia , Fallahi Poupak , Ragusa Francesca , Elia Giusy , Rosaria Paparo Sabrina , Patrizio Armando , Balestri Eugenia , Antonelli Alessandro

Objective: An enhancement of the response rate has been recently showed in patients with Graves’ ophthalmopathy (GO) treated with corticosteroids and mycophenolic acid. In GO, retro-orbital cells showed a cytokine-induced secretion of Th1 and Th2 chemokines. Since no data are present in literature about the effect of corticosteroids and mycophenolic acid on the chemokines secretion in GO orbital cells, we aim to deepen out this topic.Methods: We est...

ea0081ep1138 | Thyroid | ECE2022

Autoimmune thyroiditis and hypothyroidism: a personalized medical approach

Martina Ferrari Silvia , Ragusa Francesca , Elia Giusy , Paparo Sabrina Rosaria , Mazzi Valeria , Balestri Eugenia , Botrini Chiara , Patrizio Armando , Antonelli Alessandro , Fallahi Poupak

Autoimmune thyroid diseases (AITD) are organ specific autoimmune disorders with a T-cell-mediated immune attack directed against the thyroid. Hashimoto’s thyroiditis and Graves’ disease are the two principal AITD clinical presentations, which are characterized by hypothyroidism and thyrotoxicosis, respectively. We review the available data in literature about personalized medicine in patients with autoimmune thyroiditis (AT) and hypothyroidism. The synthetic Levothyr...

ea0092ps3-21-06 | Hypothyroidism | ETA2023

Liquid Levothyroxine (L-T4; vs. Tablet L-T4) mantains more stable tsh levels in hypothyroid patients

Fallahi Poupak , Martina Ferrari Silvia , Elia Giusy , Ragusa Francesca , Rosaria Paparo Sabrina , Balestri Eugenia , Botrini Chiara , Patrizio Armando , Mazzi Valeria , Antonelli Alessandro

Hypothyroidism is usually treated with levothyroxine (L-T4), that is present in different formulation. We aim to assess if hypothyroid patients have a better control of thyroid-stimulating hormone (TSH) levels by following a L-T4 therapy in a liquid formulation, with respect to the tablet formulation. We enrolled seven hundred hypothyroid patients treated with liquid L-T4, and three hundred and fifty hypothyroid subjects receiving tablet L-T4 (both groups were matched by age a...